EGF and lung carcinoma: Another approach proposed lipid polymeric nanoparticles (hydrophobic polymeric core, phospholipid layer and an outer layer of epidermal growth factor (EGF), PEG and distearoylphosphoethanolamine) targeting the EGF receptor (EGFR) [115], which is overexpressed in lung carcinoma [116,117].